New York Life Investment Management LLC Innoviva, Inc. Transaction History

New York Life Investment Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 05, 2024	SELL	$12.32 - $16.27 $11,112 - $14,675	-902 Reduced 2.85%	30,697 $492,000
Q3 2023 Nov 07, 2023	SELL	$12.37 - $13.89 $62,282 - $69,936	-5,035 Reduced 13.74%	31,599 $410,000
Q2 2023 Aug 04, 2023	SELL	$11.39 - $13.72 $65,321 - $78,684	-5,735 Reduced 13.54%	36,634 $466,000
Q1 2023 May 08, 2023	BUY	$10.73 - $13.6 $140,058 - $177,520	13,053 Added 44.53%	42,369 $476,000
Q4 2022 Feb 10, 2023	BUY	$11.8 - $13.78 $38,963 - $45,501	3,302 Added 12.69%	29,316 $388,000
Q3 2022 Nov 10, 2022	BUY	$11.61 - $15.22 $22,221 - $29,131	1,914 Added 7.94%	26,014 $302,000
Q2 2022 Aug 12, 2022	BUY	$14.32 - $19.88 $345,112 - $479,108	24,100 New	24,100 $356,000

229

79.2M

37.6K

300

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.33B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

Get notified when there are updates to the investment portfolio of New York Life Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on New York Life Investment Management LLC with notifications on news.